Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease. This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients? This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include: • the latest understanding of pathology and biology • current standards for investigation, imaging and diagnosis • the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease • the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression • a new chapter about immunotherapy for bladder cancer • future trends in a rapidly evolving field. 'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients. Contents: • Epidemiology and etiology • Pathology and biology • Clinical presentation • Investigations • Management of non-muscle-invasive disease • Management of muscle-invasive disease • Management of advanced and metastatic disease • Immunotherapy • Future trends • Useful resources
Presenting features include headache, alterations of visual acuity, double vision and nausea with some vomiting. Benign intracranial hypertension is resolved in some patients with morbid obesity by substantial weight loss ...
Fast Facts for Critical Care
The 4th edition of 'Fast Facts: Depression' has been fully updated using the DSM-5 diagnostic criteria and the latest recommendations from research reviews and clinical practice guidelines, and includes a new chapter on depression in women.
The aim is to ensure that the entire target area is included in the radiation field, while normal organs receive as little radiation as possible. To achieve this, several X-ray, CT and MRI studies are usually carried out.
In order to make decisions and offer quality health care, it is essential to be able to predict survival and other outcomes. This practical, evidence-based book brings together prognosis information for patients with advanced cancer.
This practical handbook reflects the importance of addressing non-motor symptoms, the need for multidisciplinary care and the use of tools that empower patients.
... cancer Opsonization of Rituximab CD20 cancer cells Chronic lymphocytic leukemia BiTE® Blinatumomab CD19/CD3 B cell acute lymphoblastic leukemia EGFR, epidermal growth factor receptor; HER2, human epidermal growth factor receptor 2.
American Journal of Ophthalmology, 90(2), 254–257. doi:10.1016/s0002-9394(14)74864-0 Bradley, J. S., Nelson, J. D., & Kimberlin, D. K. (2015). Nelson's pocket book of pediatric antimicrobial therapy (21st ed.).
... Third Edition (Kan, Stabler-Haas) Fast Facts on COMBATING NURSE BULLYING, INCIVILITY, AND WORKPLACE VIOLENCE: What Nurses Need to Know (Ciocco) Fast Facts About COMPETENCY-BASED EDUCATION IN NURSING: How to Teach Competency Mastery ...
Designated a 2014 Doodyís Core Title by Doodyís Medical Reviews Concise and comprehensive, this book covers the basics of nursing research and the essentials of how to implement Evidence Based Practice (EBP).